Molecular Advances in Neuroprotective Strategies for Ocular Diseases
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 30 August 2024 | Viewed by 70
Special Issue Editor
2. Rabin Medical Centre, Ophthalmology Department and Laboratory of Eye Research Felsenstein Medical Research Centre, Petah-Tikva 49100, Israel
Interests: procoagulant factors; anticoagulant factors; hemostasis; neuroprotection; ocular diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Ocular chronic progressive diseases, such as age-related macular degeneration (AMD), glaucoma, and diabetic retinopathy, lead to vision impairment or even irreversible blindness. Inflammation, retinal barrier disruption, leakage, and neurodegeneration are hallmark characteristics of most of these chronic conditions. In the context of the eye, “neuroprotection” refers to strategies and interventions aimed at preserving and safeguarding the neural tissues and structures essential for vision. The primary goal of neuroprotection in the eye is to prevent or slow down the degeneration of neurons, particularly those in the retina and optic nerve, to maintain and protect visual function. Neuroprotective therapy is an urgent need in ophthalmology and remains challenging. Thus, a comprehensive understanding of the involved complex mechanisms is essential for the development of new therapeutic strategies.
Therefore, this Special Issue invites manuscript submissions, including research and review papers, that update our knowledge on the molecular mechanisms of various neurodegenerative ocular diseases, focusing on new neuroprotective strategies or combined approaches that may hold significant potential for mitigating a spectrum of neurodegenerative ocular disorders and may lead to successful clinical applications.
Prof. Tami Livnat
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neuroprotection
- neurodegeneration
- neuronal cell death
- regeneration
- pyroptosis
- inflammation
- optic nerve injuries
- translational research
- photoreceptors
- retinal ganglion cells
- inflammasomes
- microglia
- complement pathways
